This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Ulta Beauty Teams With Credo to Offer Clean Beauty Items
by Zacks Equity Research
Ulta Beauty's (ULTA) partnership with Credo Beauty to offer clean beauty products is likely to strengthen its footing in the evolving clean beauty space.
HELE or EL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HELE vs. EL: Which Stock Is the Better Value Option?
Why Is Estee Lauder (EL) Up 11.9% Since Last Earnings Report?
by Zacks Equity Research
Estee Lauder (EL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
5 Consumer Staple Stocks Set to Beat Earnings Despite Coronavirus
by Vrishali Bagree
Several players in the Consumer Staples sector have been benefiting from rising demand owing to the coronavirus-led pantry loading. We have selected five stocks with an earnings beat potential.
Cosmetics Industry Outlook Prospects Dimmed by Coronavirus Woes
by Vrishali Bagree
The Cosmetics space appears to be under pressure, thanks to coronavirus-led concerns like major travel restrictions, delay in product launches and temporary store closures in some regions.
5 Consumer Staple Stocks to Trump Earnings Despite Coronavirus
by Zacks Equity Research
Several players in the Consumer Staples sector have been benefiting from increased demand owing to the coronavirus-led stockpiling. We have selected five stocks with an earnings beat potential.
Estee Lauder (EL) Q3 Earnings Beat Estimates, Sales Down
by Zacks Equity Research
Estee Lauder's (EL) third-quarter fiscal 2020 sales decline due to coronavirus-induced retail store closures.
Estee Lauder (EL) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 18.06% and 9.50%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Consumer Staples Stock Earnings for May 1: CL, CLX & EL
by Rajani Lohia
Despite the havoc created by the Coronavirus pandemic, consumer staples companies look poised for gains from spiked demand for everyday essentials.
Factors Shaping the Fate of Estee Lauder's (EL) Q3 Earnings
by Zacks Equity Research
Estee Lauder's (EL) third-quarter fiscal 2020 performance is likely to reflect impacts of store closures and reduced air travel due to coronavirus. However, online sales have been aiding.
Analysts Estimate Estee Lauder (EL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Estee Lauder (EL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inter Parfums Q1 Sales Soft, Launches Delayed Amid Coronavirus
by Zacks Equity Research
Inter Parfums (IPAR) reports dismal sales numbers in first-quarter 2020. Also, the company postponed launches due to growing coronavirus concerns.
Estee Lauder Shuts Stores, Draws for Credit Amid Coronavirus Fears
by Zacks Equity Research
Estee Lauder Companies (EL) shuts most stores in the Americas, Europe, Middle East & Africa region amid the coronavirus outbreak. Also, air travel is restricted.
Moving Average Crossover Alert: Estee Lauder
by Zacks Equity Research
The Estee Lauder Companies Inc. (EL) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Inter Parfums (IPAR) Withdraws 2020 View Due to Coronavirus
by Zacks Equity Research
Due to the coronavirus outbreak and its impact on revenues and costs, Inter Parfums (IPAR) has withdrawn full-year 2020 guidance.
Will Nu Skin Mainland China Woes Worsen Due to Coronavirus?
by Zacks Equity Research
Nu Skin (NUS) anticipates sales in Mainland China to decline 20-25% in 2020. The company puts meetings on hold in the region due to the coronavirus outbreak.
Why Is Estee Lauder (EL) Down 9.3% Since Last Earnings Report?
by Zacks Equity Research
Estee Lauder (EL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Coronavirus Steals Glitter Off These 3 Cosmetic Stocks
by Vrishali Bagree
Coronavirus-led worries weigh on the guidance of these cosmetic stocks due to reduced global travel and sluggish traffic.
Coty's Luxury Unit Looks Solid, Consumer Beauty Segment Soft
by Zacks Equity Research
Solid brand performances, innovations and strong consumer demand are aiding Coty's (COTY) Luxury business. However, challenges in the Consumer Beauty unit persist.
Estee Lauder (EL) Shares Rise on Q2 Earnings & Sales Beat
by Zacks Equity Research
Estee Lauder's (EL) second-quarter fiscal 2020 results reflect strength in Skin Care and Fragrance categories, Estee Lauder brand, travel retail and online channels.
Estee Lauder (EL) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 10.47% and 5.95%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Best of the Beauty and Social Media Earnings Charts
by Tracey Ryniec
Who has the best chart of the beauty and social media companies reporting this week?
Things to Note Ahead of Estee Lauder's (EL) Q2 Earnings
by Zacks Equity Research
Estee Lauder's (EL) second-quarter fiscal 2020 performance is likely to have benefited from growth in emerging markets, travel retail and online sales. However, currency woes remain a threat.
Estee Lauder (EL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Estee Lauder (EL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Consumer Discretionary ETFs Suffer the Coronavirus Blow?
by Sweta Jaiswal, FRM
We discuss how the rapidly spreading coronavirus can sneak in to your portfolio and hurt returns from holdings in the consumer discretionary sector.